Hunan Dongting Pharmaceutical Co., Ltd. was established in 1958 and turned into a joint-stock company in 1997 and was developed into a comprehensive enterprise dedicated to the manufacturing, marketing and sales of pharmaceutical products.The company has total assets of 689 million RMB (about 100 million USD), registered capital of 110 million RMB and over 1000 of employees among which 350 are technicians.After many years of renovation and competition, haemostatic drugs and psychotropic drugs becase the core of company products. Capacity and quality of haemostatic API, Tranexamic acid and PAMBA, are already at the top of world. Categories, strengths and dosage forms of psychotropic drugs are also in the fast lane of development, many products has been launched of antischizophrinics, antidepressants, antiepileptics, antiparkinsonism drugs, ataractics and hypnotics. Hunan Dongting has been the leading company in China of psychotropic drugs and haemostatic drugs.Hunan Dongting is a national high-tech enterprise with a provincial technical center and a provincial engineering research center of psychotropic drugs. We have got the honorary title of famous trademark and international known brand issued by local government, and we have some invention patents of manufacturing process of drugs.Hunan Dongting has established a reliable quality-assure system, all our production lines have approved by CFDA and gained GMP certificate. Production line of Tranexamic acid has approved by US FDA, MHRA, EDQM and PMDA, quality of this product complies with all common quality criteria such as ChP, USP, JP, EP.
more >
Year of Establishment:
1958
Total Assets(USD):
choose not to disclose
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Manufacturer,Trading Company,Trading Company
R&D capacity:
Annual Turnover(USD):
choose not to disclose
Main Sales Markets:
North America,Eastern Europe,Asia
Other Competitive Advantages:
Patents and Copyrights: